Interventional Cardiology: Implantable Pacemaker Products

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the implantable pacemaker products market. Implantable pacemaker products covered by this report include:

• single-chamber pacemakers, including leadless pacemakers
• dual-chamber pacemakers
• biventricular pacemakers, also known as cardiac resynchronization therapy pacemakers (CRT-P)

The global market for implantable pacemaker products is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2017-23). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 5.2% during the 2017-23 forecast, increasing from approximately $3,940.3m in 2017 to an estimated $5,325.0m in 2023.